OliX Pharma expands ocular disease pipeline

Pharma |  News | 0 Comment | 15 May, 2019

OliX Pharmaceuticals, Inc., a leading developer of RNAi therapeutics in South Korea, announced an expansion of its ocular disease pipeline. Specifically, the company announced tha...Read more

Eisai to sell anti-rheumatic injection in Japan

Pharma |  News | 0 Comment | 14 May, 2019

Eisai Co., Ltd. has entered into a license agreement with medac Gesellschaft für klinische Spezialpräparate mbH (Medac) for the commercialization of its anti-rheumatic agent metho...Read more

ReGenTree commences clinical study for Dry Eye Syndrome

Pharma |  News | 0 Comment | 13 May, 2019

ReGenTree, LLC (the Company), a joint venture company between GtreeBNT and RegeneRx Biopharmaceuticals, announced that it initiated a randomized, double masked, placebo-controlled...Read more

Takeda sells surgical patch to Ethicon for $400M

Pharma |  News | 0 Comment | 13 May, 2019

Japan headquartered Takeda Pharma has entered into an agreement to sell TachoSil®, a surgical patch designed to achieve safe, fast and reliable bleeding control, to Ethicon, a subsidiar...Read more

ASLAN signs agreement with Korean Gastric Cancer group

Pharma |  News | 0 Comment | 13 May, 2019

ASLAN Pharmaceuticals, a Singapore based clinical-stage oncology and immunology focused biopharma company, has signed an agreement with the Korean Cancer Diagnosis & Treatment Enterpris...Read more

Novartis to acquire Xiidra in a $5.3B deal

Pharma |  News | 0 Comment | 10 May, 2019

Novartis announced that it has entered into an agreement with Takeda Pharmaceutical Company Limited to acquire the assets associated with Xiidra® (lifitegrast ophthalmic solution) ...Read more

Takeda collaborates with Skyhawk to develop solutions for neurodegenerative diseases

Pharma |  News | 0 Comment | 07 May, 2019

US based Skyhawk Therapeutics, Inc. has announced a strategic collaboration with Japan headquartered Takeda Pharmaceutical Company Limited in which Skyhawk will use its SkySTAR™techno...Read more

Harbour BioMed, CTTQ unite to discover, develop and commercialize Innovative Biologics

Pharma |  News | 0 Comment | 07 May, 2019

Harbour BioMed and Chia Tai Tianqing Pharmaceutical Group Ltd. (CTTQ) are entering into a strategic alliance to discover, develop and commercialize next-generation biologics for multiple th...Read more

Meet Eppendorf at LABVOLUTION 2019: Discover the digital Eppendorf exhibition booth

Pharma |  News | 0 Comment | 03 May, 2019

For the very first time, Eppendorf invites its customers at the LABVOLUTION® 2019 in Hanover, Germany, to discover its exhibition booth in an entirely new dimension: thanks to the lates...Read more

CStone, Numab announce exclusive regional licensing agreement for ND021

Pharma |  News | 0 Comment | 03 May, 2019

CStone Pharmaceuticals and Numab Therapeutics have announced that they have entered into an exclusive regional licensing agreement for the development and commercialization of ND0...Read more

Manufacturing growth sees surging demand at CPhI South East Asia

Pharma |  News | 0 Comment | 06 May, 2019

SE Asian demand for manufacturing is being driven by recent regulatory changes and increased generics from Indonesia, Malaysia and the Philippines. These prosperous regional conditions were...Read more

Glenmark Therapeutics announces Co-Promotion Agreement with Otonomy

Pharma |  News | 0 Comment | 03 May, 2019

Glenmark Therapeutics has announced a co-promotion agreement with Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. Glenmark The...Read more

Panaxia, Rafa, PlantEXT to co-develop next-gen medical cannabis products

Pharma |  News | 0 Comment | 03 May, 2019

Panaxia Pharmaceutical Industries Israel and the pharmaceutical company Rafa, announced the signing of a collaboration agreement with PlantEXT Ltd., an Israeli-Canadian medical cannabis com...Read more

Takeda opens new global research center in San Diego

Pharma |  News | 0 Comment | 03 May, 2019

Takeda has announced the opening of a new research facility in San Diego, California. Extending Takeda’s 14-year presence in San Diego, the 165,000-square-foot facility is home to mor...Read more

ASLAN reports Q1 2019 financial results

Pharma |  News | 0 Comment | 29 Apr, 2019

ASLAN Pharmaceuticals, a clinical stage oncology and immunology focused biopharmaceutical company developing novel therapeutics for global markets, today reported financial results for the ...Read more

USFDA accepts NDA and grants priority review for Bayer’s darolutamide

Pharma |  News | 0 Comment | 29 Apr, 2019

Bayer announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic castr...Read more

Teva Pharmaceuticals issues voluntary nationwide recall of Losartan Potassium

Pharma |  News | 0 Comment | 26 Apr, 2019

Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 2...Read more

BioInvent receives €0.75 M under Mitsubishi Tanabe Pharma partnership

Pharma |  News | 0 Comment | 26 Apr, 2019

BioInvent International has announced that it has received a €0.75 million milestone payment under its collaboration with Mitsubishi Tanabe Pharma Corporation in connection with e...Read more